These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22058263)

  • 1. Clinical effects of leucoreduction of blood transfusions.
    Bilgin YM; van de Watering LM; Brand A
    Neth J Med; 2011 Oct; 69(10):441-50. PubMed ID: 22058263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting.
    Vamvakas EC
    Transfus Med Rev; 2002 Oct; 16(4):304-14. PubMed ID: 12415516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery.
    Bilgin YM; van de Watering LM; Versteegh MI; van Oers MH; Vamvakas EC; Brand A
    Transfusion; 2011 Dec; 51(12):2603-10. PubMed ID: 21645007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
    Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
    Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical benefits of the leukoreduction of blood products.
    Blajchman MA
    J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-related immunomodulation: a second hit in an inflammatory cascade?
    Bilgin YM; Brand A
    Vox Sang; 2008 Nov; 95(4):261-71. PubMed ID: 19138255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis.
    Bilgin YM; van de Watering LM; Eijsman L; Versteegh MI; van Oers MH; Brand A
    Transfus Med; 2007 Aug; 17(4):304-11. PubMed ID: 17680957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransfusion cytomegalovirus infections.
    Tegtmeier GE
    Arch Pathol Lab Med; 1989 Mar; 113(3):236-45. PubMed ID: 2537614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte-reduced blood components: patient benefits and practical applications.
    Higgins VL
    Oncol Nurs Forum; 1996 May; 23(4):659-67. PubMed ID: 8735324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions.
    Tsantes AE; Kyriakou E; Nikolopoulos GK; Stylos D; Sidhom M; Bonovas S; Douramani P; Kalantzis D; Kokoris S; Valsami S; Stamoulis K; Politou M; Foudoulaki-Paparizos L
    Blood Transfus; 2014 Apr; 12(2):232-7. PubMed ID: 24931843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned.
    Seghatchian J
    Transfus Apher Sci; 2003 Oct; 29(2):105-17. PubMed ID: 12941346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood donation and blood transfusion in Spain (1997 - 2007): the effects of demographic changes and universal leucoreduction.
    García-Erce JA; Campos A; Muñoz M
    Blood Transfus; 2010 Apr; 8(2):100-6. PubMed ID: 20383303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
    Wu Y; Zou S; Cable R; Dorsey K; Tang Y; Hapip CA; Melmed R; Trouern-Trend J; Wang JH; Champion M; Fang C; Dodd R
    Transfusion; 2010 Apr; 50(4):776-86. PubMed ID: 19912585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).
    Vamvakas EC
    Crit Care Med; 2006 May; 34(5 Suppl):S151-9. PubMed ID: 16617260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis.
    Vamvakas EC
    Vox Sang; 2007 Apr; 92(3):224-32. PubMed ID: 17348871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications.
    Bilgin YM; van de Watering LM; Versteegh MI; van Oers MH; Brand A
    Crit Care Med; 2010 Feb; 38(2):546-52. PubMed ID: 19864941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of RBC transfusions on cytokine gene expression after cardiac surgery in patients developing post-operative multiple organ failure.
    Sitniakowsky LS; Later AF; van de Watering LM; Bogaerts M; Brand A; Klautz RJ; Smit NP; van Hilten JA
    Transfus Med; 2011 Aug; 21(4):236-46. PubMed ID: 21518046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.